LPCN: Lipocine Inc. Stock

by  •  • Comments Off on LPCN: Lipocine Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17.30
Enterprise Value ($M) 13.94
Book Value ($M) 19.20
Book Value / Share 3.59
Price / Book 0.90
NCAV ($M) 19.03
NCAV / Share 3.56
Price / NCAV 0.91

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 15.64
Current Ratio 15.64

Balance Sheet (mrq) ($M)
Current Assets 20.33
Assets 20.50
Liabilities 1.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11.20
Operating Income -1.16
Net Income 0.01
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.22
Cash from Investing 2.45
Cash from Financing 0.21

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 6,453 21,005 30.72
2025-05-08 2,655 9,889 26.85
2025-05-07 1,366 7,749 17.63
2025-05-06 12,833 36,651 35.01
2025-05-05 1,934 7,989 24.21

(click for more detail)

Similar Companies
LGVN – Longeveron Inc. LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Lipocine Inc